Macrogenics (MGNX) EBT Margin (QoQ) (2012 - 2026)
Macrogenics (MGNX) EBT Margin (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Macrogenics | 254.43 Mn | 187.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15,106.00 |
| Dec 31, 2025 | -5,931.00 |
| Sep 30, 2025 | 18,561.00 |
| Jun 30, 2025 | 16,128.00 |
| Mar 31, 2025 | -28,760.00 |
| Dec 31, 2024 | -8,706.00 |
| Sep 30, 2024 | 56,641.00 |
| Jun 30, 2024 | 58,501.00 |
| Mar 31, 2024 | -64,017.00 |
| Dec 31, 2023 | -11,893.00 |
| Sep 30, 2023 | 1,675.00 |
| Jun 30, 2023 | -16,940.00 |
| Mar 31, 2023 | -20,521.00 |
| Dec 31, 2022 | 7,619.00 |
| Sep 30, 2022 | 10,096.00 |
| Jun 30, 2022 | 44,767.00 |
| Mar 31, 2022 | 211,885.00 |
| Dec 31, 2021 | -226,174.00 |
| Sep 30, 2021 | -15,924.00 |
| Jun 30, 2021 | 54,148.00 |